Literature DB >> 3419598

Parkinsonism death rates by race, sex, and geography.

J F Kurtzke1, I D Goldberg.   

Abstract

Age-adjusted death rates for Parkinson's disease (PD) in the United States from 1959 to 1961 demonstrated significantly lower rates for blacks than for whites, with rates for Oriental Americans the same as for whites. All racial groups showed a male preponderance. Both whites and blacks had a similar excess of PD death rates for residents of the four northern census regions of the US over their rates for the three southern regions. Within each region the sex and race differences remained. Thus, blacks in the US appear to be "protected" against PD, but they share the north: south gradient seen for whites. Race, sex, and geography would therefore seem to be independent risk factors for PD, providing further evidence that this may then be an acquired, environmental disease.

Entities:  

Mesh:

Year:  1988        PMID: 3419598     DOI: 10.1212/wnl.38.10.1558

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  23 in total

Review 1.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

2.  Neurologist care in Parkinson disease: a utilization, outcomes, and survival study.

Authors:  A W Willis; M Schootman; B A Evanoff; J S Perlmutter; B A Racette
Journal:  Neurology       Date:  2011-08-10       Impact factor: 9.910

3.  An international comparison of dietary protein consumption and mortality from Parkinson's disease.

Authors:  S S Coughlin; J H Pincus; P Karstaedt
Journal:  J Neurol       Date:  1992-04       Impact factor: 4.849

Review 4.  Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.

Authors:  Elisabetta Vegeto; Valeria Benedusi; Adriana Maggi
Journal:  Front Neuroendocrinol       Date:  2008-04-29       Impact factor: 8.606

5.  Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.

Authors:  M C de Rijk; C Tzourio; M M Breteler; J F Dartigues; L Amaducci; S Lopez-Pousa; J M Manubens-Bertran; A Alpérovitch; W A Rocca
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

6.  Female Sex and Brain-Selective Estrogen Benefit α-Synuclein Tetramerization and the PD-like Motor Syndrome in 3K Transgenic Mice.

Authors:  Molly M Rajsombath; Alice Y Nam; Maria Ericsson; Silke Nuber
Journal:  J Neurosci       Date:  2019-08-12       Impact factor: 6.167

7.  Dysphagia and dementia in subjects with Parkinson's disease.

Authors:  J E Bine; E M Frank; H L McDade
Journal:  Dysphagia       Date:  1995       Impact factor: 3.438

Review 8.  Prevalence of Parkinson's disease in populations of African ancestry: a review.

Authors:  Aideen McInerney-Leo; Katrina Gwinn-Hardy; Robert L Nussbaum
Journal:  J Natl Med Assoc       Date:  2004-07       Impact factor: 1.798

9.  Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.

Authors:  Nancy Bélanger; Laurent Grégoire; Paul Bédard; Thérèse Di Paolo
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

10.  Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries.

Authors:  Allison Wright Willis; Bradley A Evanoff; Min Lian; Susan R Criswell; Brad A Racette
Journal:  Neuroepidemiology       Date:  2010-01-15       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.